Scientists create 'mini-retina' in lab dish

2014-06-11 11:01
(File, AP)

(File, AP)

Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Paris - In another step towards reversing degenerative vision loss, scientists said on Tuesday they had coaxed stem cells into growing into a tiny, light-sensing retina in a lab dish.

The study is an important technical feat in using reprogrammed cells, whose discovery in 2006 has unleashed huge interest, they said.

"We have basically created a miniature human retina in a dish that not only has the architectural organisation of the retina but also has the ability to sense light," said Valeria Canto-Soler of Johns Hopkins University School of Medicine, Baltimore.

The work is the latest advance towards the goal of creating transplant cells that reverse damage to the retina, the light-capturing surface on the back of the eyeball.

Stem cells are infant cells that develop, or differentiate, into the various tissues of the body.

Human tests needed

Until 2006, the big focus was on stem cells culled from early-stage embryos, which are highly versatile but also ethically controversial.

That changed with the discovery in Japan of so-called human induced pluripotent stem cells (iPS cells), which are adult cells that have been reprogrammed to return to a youthful, pre-differentiated state.

The latest research marshalls the iPS into the right architecture for the retina, ordering the complex layers of specific photoreceptor cells which absorb and process light.

More work is needed, though, to understand how these cells transmit signals to the brain.

Experiments in a lab dish, however remarkable, still need to be validated in tests on humans before they can be incorporated into medical practice.

"Is our lab retina capable of producing a visual signal that the brain can interpret into an image? Probably not, but this is a good start," Canto-Solder said in a press release.

Japan last year gave the green light for the world's first trial on humans of iPS cells for age-related macular degeneration (AMD), which causes blindness in older people.

Six patients with AMD will be recruited in a four-year trial.

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions.
Read more on:    us  |  science
NEXT ON NEWS24X publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24


Rugby World Cup 2015

All the action from the 2015 RWC, including live coverage of all 48 matches, breaking news, fixtures, results, logs - and much more!


Rugby World Cup 2015

Tuilagi banned for five weeks
Romania rally to down Canada
Lancaster upbeat over Burgess' union future
LIVE: Fiji 12-0 Uruguay
Traffic Alerts

Are you burning the candle at both ends? Listen to your body and your emotional reactions. Know when to slow down or stop. It is more

There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.